申请人:Vankayalapati Hariprasad
公开号:US20100222381A1
公开(公告)日:2010-09-02
Compounds represented by Formula (I):
are useful in treating diseases, such as cancer, that are mediated and/or associated (at least in part) with DNMT3b activity. The compounds can be formulated as pharmaceutically acceptable compositions for administration to a subject in need thereof.
由式(I)表示的化合物在治疗疾病方面很有用,例如癌症,这些疾病与DNMT3b活性有关。这些化合物可以制备成药学上可接受的组合物,用于向需要的受试者施用。